Phase 1 trials of the Neo-Kidney Augment, a novel, personalized treatment designed to enhance or replace kidney function in patients nearing renal failure, are under way in Sweden and the United States. Developed by regenerative medicine company Tengion, the Neo-Kidney Augment uses tubular epithelial cells taken from a biopsy of a patient’s diseased kidney. Over … Continue reading Neo-Kidney Augment Phase 1 Trials Under Way
Plant Extract as Treatment to Stop Lupus and Block Kidney Damage
University of Houston researchers have found that the experimental compound CDDO (also known as bardoxolone methyl) suppresses the progression of lupus in mice, including the immune system’s attack on the kidneys. Though CDDO is synthetic, it’s derived from oleanolic acid, a natural product found in many plants and foods including olive oil, garlic, and cloves. … Continue reading Plant Extract as Treatment to Stop Lupus and Block Kidney Damage
Blood Test Predicts Tissue Injury in Kidney Transplant Patients with FSGS
An international research team from UC San Francisco, Rush University Medical Center in Chicago, and Necker Hospital in Paris has devised a blood test to identify FSGS patients at risk of repeat kidney injury following transplantation. In developing the blood panel, nicknamed FAST (FSGS Antibody Screen For Transplant), they also uncovered a potential drug … Continue reading Blood Test Predicts Tissue Injury in Kidney Transplant Patients with FSGS